Indications

The product can induce immune response in recipients following immunization.

 It is used to prevent diphtheria, tetanus and pertussis.

Highlights

1. Similar to Sanofi‘s Tripacel

2. Acellular pertussis is more safer, less adverse reactions than DTwP

3. Complete phase I, III Clinical Trial in China

4. Being registered in India

Dosage form

Freeze-dried powder for Injection

Specification

0.5 ml/vial/dose

Route of Administration

Intramuscular injection

Shelf life

24 Months